Why is Vaishali Pharma falling/rising?

As of 03-Jul, Vaishali Pharma Ltd's stock price is currently at 11.45, reflecting a decrease of 0.03 or 0.26%. The stock has underperformed its sector today by 0.74%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 3.46%, and it has seen a significant drop of 34.53% year-to-date. Despite a recent increase in delivery volume by 80.55%, the company is facing challenges, including operating losses and a weak ability to service its debt, indicated by a poor EBIT to Interest ratio of 1.57. The stock's negative performance is compounded by a low return on equity of 8.96% and a high PEG ratio of 8.8, suggesting that it is trading at a risky valuation compared to its historical performance.
In the broader market context, Vaishali Pharma's recent performance contrasts sharply with the Sensex, which has gained 7.45% year-to-date. While the stock has generated a return of -25.80% over the past year, the benchmark has increased by 4.61% during the same period. This underperformance is evident not only in the long term but also in the near term, as the stock has lagged behind the BSE500 index over the last three years, one year, and three months. Overall, the combination of weak financial fundamentals and poor market performance has contributed to the stock's decline.